| Stanley A Baranosky, RPH | |
|
2456 E Main Rd, Portsmouth, RI 02871-4025 | |
| (401) 683-3062 | |
| Not Available |
| Full Name | Stanley A Baranosky |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2456 E Main Rd, Portsmouth, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023308400 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH02099 (Rhode Island) | Primary |
| 183500000X | Pharmacist | PH14739 (Massachusetts) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Stanley A Baranosky, RPH 2456 E Main Rd, Portsmouth, RI 02871-4025 Ph: (401) 683-3062 | Stanley A Baranosky, RPH 2456 E Main Rd, Portsmouth, RI 02871-4025 Ph: (401) 683-3062 |
News Archive
Virginia Attorney General Ken Cuccinelli II has asked the U.S. Supreme Court to take the extraordinary step of leapfrogging past federal appeals courts to decide the constitutionality of the new health-care law.
In recognition of his high-impact work advancing the field of RNA-targeting medicines, the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, has awarded Scripps Research Chemistry Professor Matthew Disney, PhD, a prestigious Research Program Award, to aid Disney's development of treatments for incurable diseases such as Alzheimer's, Parkinson's, ALS and frontotemporal dementia.
A synthetic DNA vaccine candidate for Middle East respiratory syndrome coronavirus (MERS-CoV) developed at The Wistar Institute induced potent immune responses and afforded protective efficacy in non-human primate (NHP) models when given intradermally in abbreviated, low-dose immunization regimen.
Every person has some level of alexithymia, as it is the personality trait which keeps people from sharing or even understanding their own emotions. Now, one University of Missouri researcher's latest study indicates that affectionate communication, such as hugging, could help those who have high levels of alexithymia lead more fulfilling lives.
Eli Lilly and Company and Merck, known as MSD outside the United States and Canada, today announced another immuno-oncology collaboration that will evaluate abemaciclib (LY2835219), Lilly's cyclin-dependent kinase (CDK) 4 and 6 inhibitor, and Merck's KEYTRUDA (pembrolizumab) in a Phase I study across multiple tumor types.
› Verified 5 days ago
Joy Priscilla Alonzo, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3034 E Main Rd, Portsmouth, RI 02871 Phone: 401-683-1270 | |
Mr. Marcel Emile Boutin Jr., R PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2456 E Main Rd, Portsmouth, RI 02871 Phone: 401-683-3062 | |
Felecia T Tantimonico-rauchle, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3034 East Main Road, Portsmouth, RI 02871 Phone: 401-683-1270 | |
Christopher L Toro, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10 Turnpike Ave, Portsmouth, RI 02871 Phone: 401-682-2098 | |
Dr. Joseph Robert Ferrando, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2456 E Main Rd, Portsmouth, RI 02871 Phone: 401-683-3062 Fax: 401-683-9297 | |
Mr. David Bettencourt, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2456 E Main Rd, Portsmouth, RI 02871 Phone: 401-683-3062 Fax: 401-683-9297 |